A global network of non-profit organisations supporting those affected by Niemann-Pick diseases. We’re under renovation, stay tuned!

Beren Therapeutics’ Adrabetadex NDA Accepted by FDA for Infantile-Onset Niemann-Pick Type C

Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann Pick Disease Type C...

NiemannPick India: Seen, Heard, Supported – Every Step Toward Diagnosis, Care & Hope

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis

25 February 2026 Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagement Results are...